Insertion site and risk of peripheral intravenous catheter colonization and/or local infection: a post hoc analysis of the CLEAN 3 study including more than 800 catheters.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 13 03 2024
accepted: 25 05 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

Although uncommon, infections associated with peripheral intravenous catheters (PIVCs) may be responsible for severe life-threatening complications and increase healthcare costs. Few data are available on the relationship between PIVC insertion site and risk of infectious complications. We performed a post hoc analysis of the CLEAN 3 database, a randomized 2 × 2 factorial study comparing two skin disinfection procedures (2% chlorhexidine-alcohol or 5% povidone iodine-alcohol) and two types of medical devices (innovative or standard) in 989 adults patients requiring PIVC insertion before admission to a medical ward. Insertion sites were grouped into five areas: hand, wrist, forearm, cubital fossa and upper arm. We evaluated the risk of risk of PIVC colonization (i.e., tip culture eluate in broth showing at least one microorganism in a concentration of at least 1000 Colony Forming Units per mL) and/or local infection (i.e., organisms growing from purulent discharge at PIVC insertion site with no evidence of associated bloodstream infection), and the risk of positive PIVC tip culture (i.e., PIVC-tip culture eluate in broth showing at least one microorganism regardless of its amount) using multivariate Cox models. Eight hundred twenty three PIVCs with known insertion site and sent to the laboratory for quantitative culture were included. After adjustment for confounding factors, PIVC insertion at the cubital fossa or wrist was associated with increased risk of PIVC colonization and/or local infection (HR [95% CI], 1.64 [0.92-2.93] and 2.11 [1.08-4.13]) and of positive PIVC tip culture (HR [95% CI], 1.49 [1.02-2.18] and 1.59 [0.98-2.59]). PIVC insertion at the wrist or cubital fossa should be avoided whenever possible to reduce the risk of catheter colonization and/or local infection and of positive PIVC tip culture.

Identifiants

pubmed: 38840171
doi: 10.1186/s13756-024-01414-4
pii: 10.1186/s13756-024-01414-4
doi:

Substances chimiques

Chlorhexidine R4KO0DY52L
Povidone-Iodine 85H0HZU99M
Anti-Infective Agents, Local 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

57

Informations de copyright

© 2024. The Author(s).

Références

Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents. 2009;34:S38-42.
doi: 10.1016/S0924-8579(09)70565-5 pubmed: 19931816
Rickard CM, Marsh N, Webster J, Runnegar N, Larsen E, McGrail MR, et al. Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. The Lancet. 2018;392(10145):419–30.
doi: 10.1016/S0140-6736(18)31380-1
Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189–203.
doi: 10.1097/NAN.0000000000000100 pubmed: 25871866
Zanella MC, Pianca E, Catho G, Obama B, De Kraker MEA, Nguyen A, et al. Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland. Emerg Infect Dis. 2024;30(1). Available on : https://wwwnc.cdc.gov/eid/article/30/1/23-0183_article . Cited on March, 5th 2024
Drugeon B, Guenezan J, Pichon M, Devos A, Fouassin X, Neveu A, et al. Incidence, complications, and costs of peripheral venous catheter-related bacteraemia: a retrospective, single-centre study. J Hosp Infect. 2023;135:67–73.
doi: 10.1016/j.jhin.2023.02.012 pubmed: 36918069
Marsh N, Larsen EN, Takashima M, Kleidon T, Keogh S, Ullman AJ, et al. Peripheral intravenous catheter failure: a secondary analysis of risks from 11,830 catheters. Int J Nurs Stud. 2021;124:104095.
doi: 10.1016/j.ijnurstu.2021.104095 pubmed: 34689013
Guenezan J, Marjanovic N, Drugeon B, Neill RO, Liuu E, Roblot F, et al. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis. 2021;21(7):1038–48.
doi: 10.1016/S1473-3099(20)30738-6 pubmed: 33539734
Rijnders BJA, Van Wijngaerden E, Peetermans WE. Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis. 2002;35(9):1053–8.
doi: 10.1086/342905 pubmed: 12384838
Buetti N, Abbas M, Pittet D, Chraiti MN, Sauvan V, De Kraker MEA, et al. Lower risk of peripheral venous catheter-related bloodstream infection by hand insertion. Antimicrob Resist Infect Control. 2022;11(1):80.
doi: 10.1186/s13756-022-01117-8 pubmed: 35659775 pmcid: 9164319
Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, et al. Randomized controlled trial of Chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically Ill adults. Am J Respir Crit Care Med. 2012;186(12):1272–8.
doi: 10.1164/rccm.201206-1038OC pubmed: 23043083

Auteurs

Bertrand Drugeon (B)

CHU de Poitiers, Service des Urgences Adultes -SAMU, 86-Centre 15-2, Rue de La Milétrie, Poitiers, Cedex, 86021, France.
INSERM, U1070, Pharmacologie Des Agents Antimicrobiens Et Antibio-Résistances, Poitiers, France.
Alliance for Vascular Access Teaching and Research, Griffith University, Brisbane, QLD, Australia.

Nicolas Marjanovic (N)

CHU de Poitiers, Service des Urgences Adultes -SAMU, 86-Centre 15-2, Rue de La Milétrie, Poitiers, Cedex, 86021, France.
INSERM CIC1402, CHU de Poitiers, Poitiers, France.

Matthieu Boisson (M)

INSERM, U1070, Pharmacologie Des Agents Antimicrobiens Et Antibio-Résistances, Poitiers, France.
Université de Poitiers, UFR de Médecine Pharmacie, Poitiers, France.
Service d'Anesthésie Et Réanimations Et Médecine Péri-Opératoire, CHU de Poitiers, Poitiers, France.

Niccolò Buetti (N)

Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Université Paris-Cité, INSERM, IAME UMR 1137, 75018, Paris, France.

Olivier Mimoz (O)

CHU de Poitiers, Service des Urgences Adultes -SAMU, 86-Centre 15-2, Rue de La Milétrie, Poitiers, Cedex, 86021, France. olivier.mimoz@chu-poitiers.fr.
INSERM, U1070, Pharmacologie Des Agents Antimicrobiens Et Antibio-Résistances, Poitiers, France. olivier.mimoz@chu-poitiers.fr.
Université de Poitiers, UFR de Médecine Pharmacie, Poitiers, France. olivier.mimoz@chu-poitiers.fr.

Jérémy Guenezan (J)

CHU de Poitiers, Service des Urgences Adultes -SAMU, 86-Centre 15-2, Rue de La Milétrie, Poitiers, Cedex, 86021, France.
INSERM, U1070, Pharmacologie Des Agents Antimicrobiens Et Antibio-Résistances, Poitiers, France.
Université de Poitiers, UFR de Médecine Pharmacie, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH